Teladoc Health (Teladoc Health) Cash And Cash Equivalents

: USD1,124 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

Teladoc Health's quarterly cash and cash equivalents increased from Jun. 2023 (USD958.70 Mil) to Sep. 2023 (USD1,030.53 Mil) and increased from Sep. 2023 (USD1,030.53 Mil) to Dec. 2023 (USD1,123.68 Mil).

Teladoc Health's annual cash and cash equivalents increased from Dec. 2021 (USD893.48 Mil) to Dec. 2022 (USD918.18 Mil) and increased from Dec. 2022 (USD918.18 Mil) to Dec. 2023 (USD1,123.68 Mil).

Teladoc Health Cash And Cash Equivalents Historical Data

The historical data trend for Teladoc Health's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teladoc Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

514.35

733.32

893.48

918.18

1,123.68

Teladoc Health Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash And Cash Equivalents																918.18	888.58	958.70	1,030.53	1,123.68

Teladoc Health Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Teladoc Health (NYSE:TDOC) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Teladoc Health Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Teladoc Health's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Teladoc Health (Teladoc Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Teladoc Health Inc (NYSE:TDOC) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

TDOC:Mexico 4LL:Germany T2DH34:Brazil

Address

2 Manhattanville Road, Suite 203, Purchase, NY, USA, 10577

Website

https://www.teladochealth.com

Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members; it has also started to market directly to consumers while expanding its service portfolio.

Executives

Daniel Trencher	officer: SVP Corporate Strategy	2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Vidya Raman-tangella	officer: Chief Medical Officer	2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Karen L Daniel	director	2801 80TH STREET, KENOSHA WI 53141
Jason N Gorevic	director, officer: President & CEO
Andrew Turitz	officer: SVP - Business Development	C/O TELADOC, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Stephany Verstraete	officer: Chief Marketing Officer	C/O TELADOC, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Adam C Vandervoort	officer: Chief Legal Officer, Secretary	485 MADISON AVENUE, NEW YORK NY 10022
Mala Murthy	officer: Chief Financial Officer	C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Richard J Napolitano	officer: Chief Accounting Officer	MSCI INC., 7 WORLD TRADE CENTER, 250 GREENWICH STREET, 49TH FLOOR, NEW YORK NY 10007
Arnnon Geshuri	officer: Chief Human Resources Officer	2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Laizer Kornwasser	officer: PRESIDENT, ENTERPRISE GROWTH	100 PARSONS POND DRIVE, FRANKLIN LAKES NJ 07417
Michael Willem Waters	officer: CHIEF OPERATING OFFICER	2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Jason Eric Evans	director	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Claus Torp Jensen	officer: Chief Innovation Officer	2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Sandra L Fenwick	director	C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577